RAP 0.00% 20.5¢ raptor resources limited

well the obvious difference is in performance. They didn't...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 141 Posts.
    lightbulb Created with Sketch. 9
    well the obvious difference is in performance. They didn't even apply to be a class 2 with fda. Yes, they may improve over time, but any successful model is going to face competition eventually. RAP has a very solid advantage in being diagnostically capable already
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.